Literature DB >> 8198129

Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.

R C Green1, S A Narod, J Morasse, T L Young, J Cox, G W Fitzgerald, P Tonin, O Ginsburg, S Miller, S Jothy.   

Abstract

Hereditary nonpolyposis colon cancer (HNPCC) is an autosomal dominant trait responsible for approximately 6% of colorectal cancers. Linkage of the HNPCC trait to the D2S123 locus on 2p15-16 has previously been reported in two families. This HNPCC locus is now designated "COCA1." We have tested seven Canadian HNPCC families, who have a variety of clinical presentations, for linkage to a panel of microsatellite polymorphisms in the vicinity of D2S123. One family was clearly linked to the COCA1 locus (LOD = 4.21), and a second family is likely to be linked (LOD = 0.92). In three families linkage was excluded. In the remaining two families the data were inconclusive. In the linked family, individuals with cancer of the endometrium or ureter share a common haplotype with 12 family members with colorectal cancer. This supports the suspected association between these extracolonic neoplasms and the HNPCC syndrome. In addition, five of the six individuals with adenomatous polyps (but no colorectal cancer) have the same haplotype as the affected individuals, while the sixth carries a recombination. One individual with colorectal cancer carries a recombination that places the COCA1 locus telomeric to D2S123. This study localizes the COCA1 gene to an 8-cM region that is consistent with the location of the hMSH2 gene. We also confirm that families presently classified as HNPCC are genetically heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198129      PMCID: PMC1918192     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Frequency of hereditary colorectal carcinoma.

Authors:  J P Mecklin
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Incorrect specification of marker allele frequencies: effects on linkage analysis.

Authors:  N B Freimer; L A Sandkuijl; S M Blower
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

4.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource.

Authors:  H T Lynch; W Kimberling; W A Albano; J F Lynch; K Biscone; G S Schuelke; A A Sandberg; M Lipkin; E E Deschner; Y B Mikol
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

7.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies.

Authors:  H T Lynch; G S Schuelke; W J Kimberling; W A Albano; J F Lynch; K A Biscone; M L Lipkin; E E Deschner; Y B Mikol; A A Sandberg
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

8.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

9.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

View more
  6 in total

1.  The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.

Authors:  B Bapat; L Xia; L Madlensky; A Mitri; P Tonin; S A Narod; S Gallinger
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

2.  Evidence for genetic anticipation in non-Mendelian diseases.

Authors:  A D Paterson; J L Kennedy; A Petronis
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Authors:  W D Foulkes; I Thiffault; S B Gruber; M Horwitz; N Hamel; C Lee; J Shia; A Markowitz; A Figer; E Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; J N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; A De La Chapelle; J Boyd; K Offit; G Rennert; G Chong; N A Ellis
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

Review 4.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

5.  Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.

Authors:  N J Froggatt; J Koch; R Davies; D G Evans; A Clamp; O W Quarrell; J Weissenbach; S V Hodgson; B A Ponder; D E Barton
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

6.  A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect.

Authors:  Lesa M Dawson; Kerri N Smith; Salem Werdyani; Robyn Ndikumana; Cindy Penney; Louisa L Wiede; Kendra L Smith; Justin A Pater; Andrée MacMillan; Jane Green; Sheila Drover; Terry-Lynn Young; Darren D O'Rielly
Journal:  Mol Genet Genomic Med       Date:  2019-11-28       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.